Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
Journal of Neurotrauma|June 7, 2020
Developmental Alterations in Cortical Organization and Socialization in Adolescents Who Sustained a Traumatic Brain Injury in Early ChildhoodElisabeth A Wilde, Tricia L Merkley, Hannah M Lindsey, et al.
Blood|February 14, 2018
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experienceSusan O'Brien, Richard R Furman, Steven Coutre, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2016
The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitorsJason M Cox, Hong D Chu, Jeffrey T Kuethe, et al.
British Journal of Haematology|June 7, 2018
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trialsJeffrey Jones, Anthony Mato, Steven Coutre, et al.
Journal of the International Neuropsychological Society : JINS|August 29, 2013
How functional connectivity between emotion regulation structures can be disrupted: preliminary evidence from adolescents with moderate to severe traumatic brain injuryMary R Newsome, Randall S Scheibel, Andrew R Mayer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 15, 2026
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosisElizabeth M Parzych, Mamadou A Bah, Nicholas J Tursi, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Mineralocorticoid receptor antagonists: identification of heterocyclic amide replacements in the oxazolidinedione seriesJason M Cox, Hong D Chu, Christine Yang, et al.
Journal of Clinical Medicine|May 25, 2024
Postnatal Brain Trajectories and Maternal Intelligence Predict Childhood Outcomes in Complex CHDVincent K Lee, Rafael Ceschin, William T Reynolds, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2013
Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonistsChristine Yang, Hong C Shen, Zhicai Wu, et al.
Contemporary Clinical Trials|April 2, 2023
Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health recordChi D Chu, Kristin M Lenoir, Nayanjot Kaur Rai, et al.
Pageof 31